Clinical trials: sponsored by Vanda Pharmaceuticals
Hepatic Impairment
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
The purpose of this research study is to understand whether there is any difference in the amount of tasimelteon (including its breakdown products) in the blood in individuals with mild or moderate liver disease compared to…
- Trial name
- NCT01271387
- Testing
- tasimelteon
- Where
- United States
- Volunteers
- 29 people, healthy volunteers welcome
- Sponsor
- Vanda Pharmaceuticals
Excessive Somnolence
VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
The purpose of this study is to determine the safety and efficacy of VSF-173 compared to placebo in treatment of induced excessive sleepiness.
- Trial name
- NCT00467441
- Testing
- VSF-173
- Where
- France
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Vanda Pharmaceuticals